Glaukos Corp Stock EBITDA

GKOS Stock

USD 156.39 0.12 0.08%

Glaukos Corp fundamentals help investors to digest information that contributes to Glaukos Corp's financial success or failures. It also enables traders to predict the movement of Glaukos Stock. The fundamental analysis module provides a way to measure Glaukos Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Glaukos Corp stock.

		Last Reported	Projected for Next Year
	EBITDA	-73.9 M	-70.2 M

EBITDA is likely to gain to about (70.2 M) in 2025.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Glaukos Corp Company EBITDA Analysis

Glaukos Corp's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Glaukos Corp EBITDA

(82.12 M)

Most of Glaukos Corp's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glaukos Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Glaukos EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Glaukos Corp is extremely important. It helps to project a fair market value of Glaukos Stock properly, considering its historical fundamentals such as EBITDA. Since Glaukos Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Glaukos Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Glaukos Corp's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Long Term Debt	Short Term Investments	Treasury Stock	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Short Term Debt	Current Deferred Revenue	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.9	0.9	-0.86	0.81	0.97	0.9	0.93	0.83	0.94	0.89	0.48	0.8	0.86	0.9	-0.73	-0.29	0.78	0.95	0.98	0.94	0.94
Total Stockholder Equity	0.9		0.65	-0.65	0.57	0.87	0.64	0.93	0.88	0.79	0.89	0.26	0.87	0.66	0.89	-0.79	-0.45	0.78	0.92	0.92	0.85	0.79
Net Debt	0.9	0.65		-0.94	0.87	0.83	0.98	0.8	0.64	0.89	0.77	0.6	0.58	0.93	0.69	-0.54	-0.02	0.6	0.84	0.87	0.9	0.93
Retained Earnings	-0.86	-0.65	-0.94		-0.94	-0.86	-0.92	-0.8	-0.74	-0.88	-0.74	-0.57	-0.59	-0.88	-0.75	0.61	0.17	-0.68	-0.83	-0.81	-0.81	-0.91
Accounts Payable	0.81	0.57	0.87	-0.94		0.84	0.86	0.69	0.69	0.87	0.61	0.65	0.56	0.84	0.74	-0.59	-0.23	0.69	0.74	0.72	0.69	0.87
Net Receivables	0.97	0.87	0.83	-0.86	0.84		0.84	0.88	0.88	0.92	0.84	0.53	0.81	0.8	0.95	-0.81	-0.48	0.88	0.9	0.91	0.84	0.91
Total Liab	0.9	0.64	0.98	-0.92	0.86	0.84		0.79	0.63	0.89	0.75	0.57	0.61	0.9	0.7	-0.52	-0.03	0.59	0.85	0.88	0.89	0.93
Total Current Assets	0.93	0.93	0.8	-0.8	0.69	0.88	0.79		0.91	0.85	0.98	0.34	0.84	0.8	0.83	-0.81	-0.35	0.79	0.95	0.94	0.95	0.86
Common Stock	0.83	0.88	0.64	-0.74	0.69	0.88	0.63	0.91		0.76	0.88	0.37	0.78	0.68	0.87	-0.9	-0.61	0.89	0.82	0.79	0.75	0.76
Long Term Debt	0.94	0.79	0.89	-0.88	0.87	0.92	0.89	0.85	0.76		0.8	0.54	0.85	0.89	0.82	-0.67	-0.28	0.75	0.89	0.9	0.87	0.92
Short Term Investments	0.89	0.89	0.77	-0.74	0.61	0.84	0.75	0.98	0.88	0.8		0.29	0.79	0.77	0.78	-0.82	-0.36	0.78	0.88	0.9	0.94	0.79
Treasury Stock	0.48	0.26	0.6	-0.57	0.65	0.53	0.57	0.34	0.37	0.54	0.29		0.25	0.51	0.44	-0.23	-0.08	0.38	0.44	0.41	0.39	0.68
Intangible Assets	0.8	0.87	0.58	-0.59	0.56	0.81	0.61	0.84	0.78	0.85	0.79	0.25		0.61	0.79	-0.7	-0.45	0.73	0.84	0.82	0.76	0.71
Property Plant Equipment	0.86	0.66	0.93	-0.88	0.84	0.8	0.9	0.8	0.68	0.89	0.77	0.51	0.61		0.61	-0.6	-0.14	0.65	0.8	0.83	0.84	0.87
Net Tangible Assets	0.9	0.89	0.69	-0.75	0.74	0.95	0.7	0.83	0.87	0.82	0.78	0.44	0.79	0.61		-0.79	-0.51	0.84	0.86	0.85	0.76	0.82
Short Term Debt	-0.73	-0.79	-0.54	0.61	-0.59	-0.81	-0.52	-0.81	-0.9	-0.67	-0.82	-0.23	-0.7	-0.6	-0.79		0.77	-0.97	-0.69	-0.68	-0.66	-0.61
Current Deferred Revenue	-0.29	-0.45	-0.02	0.17	-0.23	-0.48	-0.03	-0.35	-0.61	-0.28	-0.36	-0.08	-0.45	-0.14	-0.51	0.77		-0.79	-0.25	-0.21	-0.13	-0.17
Long Term Debt Total	0.78	0.78	0.6	-0.68	0.69	0.88	0.59	0.79	0.89	0.75	0.78	0.38	0.73	0.65	0.84	-0.97	-0.79		0.71	0.7	0.66	0.68
Capital Surpluse	0.95	0.92	0.84	-0.83	0.74	0.9	0.85	0.95	0.82	0.89	0.88	0.44	0.84	0.8	0.86	-0.69	-0.25	0.71		0.98	0.93	0.94
Net Invested Capital	0.98	0.92	0.87	-0.81	0.72	0.91	0.88	0.94	0.79	0.9	0.9	0.41	0.82	0.83	0.85	-0.68	-0.21	0.7	0.98		0.97	0.93
Net Working Capital	0.94	0.85	0.9	-0.81	0.69	0.84	0.89	0.95	0.75	0.87	0.94	0.39	0.76	0.84	0.76	-0.66	-0.13	0.66	0.93	0.97		0.89
Capital Stock	0.94	0.79	0.93	-0.91	0.87	0.91	0.93	0.86	0.76	0.92	0.79	0.68	0.71	0.87	0.82	-0.61	-0.17	0.68	0.94	0.93	0.89

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Glaukos Corp

Ebitda Over Time

Glaukos Ebitda

Ebitda

(70.21 Million)

At this time, Glaukos Corp's EBITDA is comparatively stable compared to the past year.

According to the company disclosure, Glaukos Corp reported earnings before interest,tax, depreciation and amortization of (82.12 Million). This is 109.36% lower than that of the Health Care Equipment & Supplies sector and 112.78% lower than that of the Health Care industry. The ebitda for all United States stocks is 102.11% higher than that of the company.

Glaukos EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glaukos Corp's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Glaukos Corp could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics of similar companies.

Glaukos Corp is currently under evaluation in ebitda category among its peers.

Glaukos Corp ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Glaukos Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Glaukos Corp's managers, analysts, and investors.

Environmental

Governance

Social

Glaukos Corp Institutional Holders

Institutional Holdings refers to the ownership stake in Glaukos Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Glaukos Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Glaukos Corp's value.

		Shares
Geode Capital Management, Llc	2024-09-30	1.2 M
Fred Alger Management, Llc	2024-09-30	1.1 M
Driehaus Capital Management Llc	2024-09-30	861.6 K
Artisan Partners Limited Partnership	2024-09-30	795.2 K
Loomis, Sayles & Company Lp	2024-09-30	673.8 K
Morgan Stanley - Brokerage Accounts	2024-09-30	662.5 K
Gilder Gagnon Howe & Co Llc	2024-09-30	658.6 K
Charles Schwab Investment Management Inc	2024-09-30	641.8 K
Summit Partners Public Asset Management, Llc	2024-09-30	617.4 K
Blackrock Inc	2024-09-30	8.5 M
Fmr Inc	2024-09-30	6.6 M

Glaukos Fundamentals

	Return On Equity	-0.26
	Return On Asset	-0.0774
	Profit Margin	(0.42) %
	Operating Margin	(0.26) %
	Current Valuation	8.52 B
	Shares Outstanding	55.14 M
	Shares Owned By Insiders	3.19 %
	Shares Owned By Institutions	96.81 %
	Number Of Shares Shorted	3.04 M
	Price To Earning	94.70 X
	Price To Book	12.91 X
	Price To Sales	23.95 X
	Revenue	314.71 M
	Gross Profit	276.06 M
	EBITDA	(82.12 M)
	Net Income	(134.66 M)
	Cash And Equivalents	391.19 M
	Cash Per Share	8.22 X
	Total Debt	383.74 M
	Debt To Equity	0.68 %
	Current Ratio	6.78 X
	Book Value Per Share	12.13 X
	Cash Flow From Operations	(57.76 M)
	Short Ratio	4.86 X
	Earnings Per Share	(2.92) X
	Price To Earnings To Growth	1.64 X
	Target Price	155.25
	Number Of Employees	907
	Beta	1.03
	Market Capitalization	8.63 B
	Total Asset	940.41 M
	Retained Earnings	(599.07 M)
	Working Capital	321.45 M
	Current Asset	104.14 M
	Current Liabilities	20.36 M
	Net Asset	940.41 M

About Glaukos Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Glaukos Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glaukos Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glaukos Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Glaukos Stock Analysis

When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC